In trading on Friday, shares of Vertex Pharmaceuticals, Inc. (Symbol: VRTX) touched a new 52-week high of $239.82/share. That's a 35.98% rise, or $63.46 per share from the 52-week low of $176.36 set back on 10/06/2021. That means at today's intraday high, any investor who purchased VRTX stock any time over the past 52 weeks has an unrealized gain, including company insiders.
Over the past six months, insiders have been scooping up shares, and those bets are now paying off handsomely. As summarized by the table below, VRTX has seen 2 different instances of insiders buying over the trailing six month period.
| Purchased | Insider | Title | Shares | Price/Share | Value |
|---|---|---|---|---|---|
| 08/02/2021 | Bruce I. Sachs | Director | 15,000 | $197.91 | $2,968,650.00 |
| 08/19/2021 | Reshma Kewalramani | CEO & President | 10,000 | $195.65 | $1,956,491.60 |
The chart below shows where VRTX has traded over the past year, with the 50-day and 200-day moving averages included.
In afternoon trading on Friday, VRTX shares are changing hands at $239.50/share, slightly below the new 52-week high.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
